subject area of
- A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen Academic Article
- Adjuvant Endocrine Therapy in Hormone Receptor-Positive Postmenopausal Breast Cancer: Evolution of NCCN, ASCO, and St Gallen Recommendations Academic Article
- Adjuvant endocrine therapies for pre-/perimenopausal women Academic Article
- Advances in osteoporosis therapy. 2003 update of practical guidelines. Academic Article
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction Academic Article
- Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis Academic Article
- Breast Cancer Prevention with Selective Estrogen Receptor Modulators Academic Article
- Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Academic Article
- Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene Academic Article
- Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer Academic Article
- Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates Academic Article
- Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial Academic Article
- Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis Academic Article
- Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators Academic Article
- Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study Academic Article
- Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings Academic Article
- Endocrine therapy: is the first generation of targeted drugs the last? Academic Article
- Hypercoagulable States Academic Article
- IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis Academic Article
- Preparation and Evaluation of Carborane Analogues of Tamoxifen Academic Article
- Raloxifene use in clinical practice Academic Article
- Raloxifene: handle with care. Academic Article
- Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis Academic Article
- Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study Academic Article
- Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review Academic Article
- The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer Academic Article